General Announcement::Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Feb-2019 11:35:43
Status
New
Announcement Sub Title
Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris
Announcement Reference
SG190220OTHR19LP
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
20/02/2019 09:05:00
Description (Please provide a detailed description of the event in the box below)
Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris , an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting

Attachments

PR_SGX_20022019.pdf
Total size =3230K